ArticleProtein engineering, design & selection : PEDS2018

A novel dual-cytokine-antibody fusion protein for the treatment of CD38-positive malignancies.

Roberto De Luca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.